Literature DB >> 8878435

Demonstration of an osteoblast defect in two cases of human malignant osteopetrosis. Correction of the phenotype after bone marrow transplant.

D Lajeunesse1, L Busque, P Ménard, M G Brunette, Y Bonny.   

Abstract

Osteopetrosis is an inherited disorder characterized by bone sclerosis due to reduced bone resorption. Here we report that human osteopetrotic osteoblast-like (Ob) cells express a defective phenotype in primary cultures in vitro, and that bone marrow transplant (BMT) corrects osteoblast function. DNA analysis at polymorphic short-tandem repeat loci from donor, recipient, and primary Ob-like cells pre-BMT and 2 yr post-BMT revealed that Ob were still of recipient origin post-BMT. Osteopetrotic Ob-like cells obtained pre-BMT showed normal and abnormal 1,25(OH)2D3-induced alkaline phosphatase (ALPase) and osteocalcin production, respectively, and failed to produce macrophage colony-stimulating factor (M-CSF) in response to IL-1a and TNF-alpha. These parameters were all normalized in primary Ob-like cells prepared 2 yr post-BMT. X-linked clonality analysis at the human androgen receptor (HUMARA) locus revealed that osteoblasts showed a polyclonal and an oligoclonal derivation pre- and post-BMT respectively, indicating that a limited number of progenitor reconstituted this population. Because osteoblasts were still of recipient origin post-BMT, this suggests that functional osteoclasts, due to the replacement of hematopoeitic cells, provided a local microenvironment in vivo triggering the differentiation and/or recruitment of a limited number of functional osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878435      PMCID: PMC507623          DOI: 10.1172/JCI118984

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Bone formation in organ cultures of bone marrow.

Authors:  E A Luria; M E Owen; A J Friedenstein; J F Morris; S A Kuznetsow
Journal:  Cell Tissue Res       Date:  1987-05       Impact factor: 5.249

3.  The osteopetrotic rabbit: skeletal cytology and ultrastructure.

Authors:  S C Marks; C A MacKay; M F Seifert
Journal:  Am J Anat       Date:  1987-03

4.  Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse.

Authors:  R Felix; M G Cecchini; W Hofstetter; P R Elford; A Stutzer; H Fleisch
Journal:  J Bone Miner Res       Date:  1990-07       Impact factor: 6.741

Review 5.  Action of the colony-stimulating factor, CSF-1.

Authors:  E R Stanley
Journal:  Ciba Found Symp       Date:  1986

6.  Development of osteogenic tissue in diffusion chambers from early precursor cells in bone marrow of adult rats.

Authors:  H J Mardon; J Bee; K von der Mark; M E Owen
Journal:  Cell Tissue Res       Date:  1987-10       Impact factor: 5.249

7.  Tumor necrosis factor type alpha (cachectin) stimulates mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2.

Authors:  K Sato; K Kasono; Y Fujii; M Kawakami; T Tsushima; K Shizume
Journal:  Biochem Biophys Res Commun       Date:  1987-05-29       Impact factor: 3.575

8.  Recombinant human interleukin 1 alpha and beta stimulate mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2.

Authors:  K Sato; Y Fujii; S Asano; T Ohtsuki; M Kawakami; K Kasono; T Tsushima; K Shizume
Journal:  Biochem Biophys Res Commun       Date:  1986-11-26       Impact factor: 3.575

9.  Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.

Authors:  A Fischer; C Griscelli; W Friedrich; B Kubanek; R Levinsky; G Morgan; J Vossen; G Wagemaker; P Landais
Journal:  Lancet       Date:  1986-11-08       Impact factor: 79.321

10.  Kinetics and differentiation of marrow stromal cells in diffusion chambers in vivo.

Authors:  I Bab; B A Ashton; D Gazit; G Marx; M C Williamson; M E Owen
Journal:  J Cell Sci       Date:  1986-08       Impact factor: 5.285

View more
  10 in total

Review 1.  Bisphosphonates: effects on osteoblast.

Authors:  Nicola Maruotti; Addolorata Corrado; Anna Neve; Francesco Paolo Cantatore
Journal:  Eur J Clin Pharmacol       Date:  2012-02-09       Impact factor: 2.953

2.  Osteocalcin synthesis by human osteoblasts from normal and osteoarthritic bone after vitamin D3 stimulation.

Authors:  Francesco Paolo Cantatore; Addolorata Corrado; Maria Grano; Laura Quarta; Silvia Colucci; Nadia Melillo
Journal:  Clin Rheumatol       Date:  2004-12       Impact factor: 2.980

Review 3.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

4.  Treatment with licofelone prevents abnormal subchondral bone cell metabolism in experimental dog osteoarthritis.

Authors:  D Lajeunesse; J Martel-Pelletier; J C Fernandes; S Laufer; J-P Pelletier
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

5.  Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production.

Authors:  Denis Couchourel; Isabelle Aubry; Aline Delalandre; Martin Lavigne; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Daniel Lajeunesse
Journal:  Arthritis Rheum       Date:  2009-05

6.  Dissociation between bone resorption and bone formation in osteopenic transgenic mice.

Authors:  D A Corral; M Amling; M Priemel; E Loyer; S Fuchs; P Ducy; R Baron; G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

7.  Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

Authors:  A Del Fattore; B Peruzzi; N Rucci; I Recchia; A Cappariello; M Longo; D Fortunati; P Ballanti; M Iacobini; M Luciani; R Devito; R Pinto; M Caniglia; E Lanino; C Messina; S Cesaro; C Letizia; G Bianchini; H Fryssira; P Grabowski; N Shaw; N Bishop; D Hughes; R P Kapur; H K Datta; A Taranta; R Fornari; S Migliaccio; A Teti
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

8.  The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein.

Authors:  Kelitha Maxis; Aline Delalandre; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicolas Duval; Daniel Lajeunesse
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts.

Authors:  Frédéric Massicotte; Isabelle Aubry; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Julio Fernandes; Daniel Lajeunesse
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

10.  Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis.

Authors:  Anna Taranta; Silvia Migliaccio; Irene Recchia; Maurizio Caniglia; Matteo Luciani; Giulio De Rossi; Carlo Dionisi-Vici; Rita M Pinto; Paola Francalanci; Renata Boldrini; Edoardo Lanino; Giorgio Dini; Giuseppe Morreale; Stuart H Ralston; Anna Villa; Paolo Vezzoni; Domenico Del Principe; Flaminia Cassiani; Giuseppe Palumbo; Anna Teti
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.